The promise of neurophenotyping psychiatric symptoms implies a need for methods that
yield reliable and valid measures of brain activity in individual patients. Balodis and Potenza
(1) have provided a comprehensive and nuanced review of the use of the monetary
incentive delay (MID) task to probe symptoms related to addiction. In this commentary, we
briefly reflect on the history of the MID task, situate these findings within the broader context
of other disorders, and speculate about implications for research and practice. The first …